News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ENZ market cap is 55.84M. The company's latest EPS is USD 0.3961 and P/E is 2.68.
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.28M | 16.34M | 16.11M | -19.66M | 7.81M |
| Operating Income | -9.91M | -12.98M | -15.65M | 13.8M | -5.48M |
| Net Income | -10.64M | -11.32M | -15.19M | 57.43M | -6.62M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 110.1M | 76.02M | 117.73M | 107.07M | 31.06M |
| Operating Income | 1.73M | -30.37M | 692k | -15.01M | -24.74M |
| Net Income | 2.49M | -28.52M | 7.88M | -18.26M | 20.29M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 85.2M | 76.45M | 72.06M | 121.88M | 106.31M |
| Total Liabilities | 40.21M | 43.62M | 53.13M | 43.42M | 32.03M |
| Total Equity | 44.99M | 32.83M | 18.93M | 78.46M | 74.28M |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.64M | 112.54M | 113.69M | 95.86M | 121.88M |
| Total Liabilities | 20.61M | 54.16M | 45.11M | 41.4M | 43.42M |
| Total Equity | 86.03M | 58.38M | 68.59M | 54.46M | 78.46M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.69M | -14.89M | -19.95M | -36.98M | -13.37M |
| Investing | -652k | -1.52M | -2.19M | 98.98M | -254k |
| Financing | -95k | -157k | 3.12M | -1.13M | -518k |
| Year End July 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.81M | -17.18M | 387k | -16.59M | -36.98M |
| Investing | -8.13M | -2.17M | -34.5M | 25.22M | 98.98M |
| Financing | 4.19M | 7M | -242k | -241k | -1.13M |
| Market Cap | 55.84M |
| Price to Earnings Ratio | 2.68 |
| Price to Sales Ratio | 1.75 |
| Price to Cash Ratio | 0.66 |
| Price to Book Ratio | 0.69 |
| Dividend Yield | - |
| Shares Outstanding | 51.23M |
| Average Volume (1 week) | 156.3k |
| Average Volume (1 Month) | 109.09k |
| 52 Week Change | -57.92% |
| 52 Week High | 2.74 |
| 52 Week Low | 1.05 |
| Spread (Intraday) | 0.06 (5.41%) |
| Company Name | Enzo Biochem Inc |
| Address |
81 executive blvd. ste 3 farmingdale, new york 11735 |
| Website | https://www.enzo.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
